CSPC Pharmaceutical Group has been granted a patent for a compound useful in treating HIF-related and/or EPO-related diseases. The patent also covers the preparation method and drug composition containing the compound. GlobalData’s report on CSPC Pharmaceutical Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on CSPC Pharmaceutical Group, Anti-bacterial thiazole derivatives was a key innovation area identified from patents. CSPC Pharmaceutical Group's grant share as of May 2024 was 50%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent (Publication Number: US11981669B2) discloses a compound of formula (I) and its various forms, including tautomers, optical isomers, N-oxides, solvates, and pharmaceutically acceptable salts. The compound can also be of formula (II), (III), or (IV), with ring A selected from specific options like pyridine and pyrazine. Additionally, the compound includes specific substituents like halogens, alkyl groups, and aromatic rings, making it suitable for pharmaceutical compositions.
Furthermore, the patent covers methods for treating HIF-related and EPO-related diseases, such as anemia, kidney disease, inflammation, cancer, and metabolic disorders, by administering the disclosed compound. The method aims to stabilize HIFa, promote EPO production, and enhance iron intake and utilization in patients. The patent also includes a method for preparing the compound by reacting specific intermediates under defined conditions. Overall, the patent provides a comprehensive framework for utilizing the compound in treating various medical conditions and highlights its potential in addressing a wide range of diseases and disorders effectively.
To know more about GlobalData’s detailed insights on CSPC Pharmaceutical Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
